Canaccord Genuity Group Reaffirms “Hold” Rating for Inari Medical (NASDAQ:NARI)
Canaccord Genuity Group reiterated their hold rating on shares of Inari Medical (NASDAQ:NARI – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. Canaccord Genuity Group currently has a $80.
With two other projects in Memot (Cambodia) and North Laverton (WA), Emerald is positioning itself to compete with top-tier ...
Fintel reports that on January 7, 2025, Canaccord Genuity initiated coverage of Rollins (NYSE:ROL) with a Hold recommendation ...
Canaccord Genuity Group reissued their buy rating on shares of Avation (LON:AVAP – Free Report) in a research note published on Tuesday morning, Marketbeat Ratings reports. They currently have a GBX ...
Canaccord Genuity maintained its price target on Antofagasta on Monday at 2,065p on the back of improving year-on-year profit ...
Canaccord Genuity analyst Kai Korschelt reiterated a Buy rating on Zegona Communications (ZEG – Research Report) today and set a price target ...
On Tuesday, Alight Inc (ALIT) stock saw a decline, ending the day at $6.78 which represents a decrease of $-0.09 or -1.31% from the prior close of $6.87. The stock opened at $6.92 and touched a low of ...
Yet with management having said that trading had been in line with its full-year expectations, Canaccord was left ...
Analyst Whitney Ijem from Canaccord Genuity maintained a Buy rating on Arcturus Therapeutics (ARCT – Research Report) and keeping the price ...
Jefferies has recently raised Bark Inc (BARK) stock to Buy rating, as announced on March 5, 2024, according to Finviz. Earlier, on December 19, 2023, Jefferies had initiated the stock to Hold, setting ...
SolarEdge Technologies (NASDAQ:SEDG – Free Report) had its price target increased by Canaccord Genuity Group from $16.00 to $18.00 in a research report released on Tuesday,Benzinga reports. They ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback